Costeffectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive earlystage breast cancer

Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer

14:18 EDT 27 May 2019 | Nature Publishing

More From BioPortfolio on "Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer"